Auric Goldfinger's Short List Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Auric Goldfinger's Short List

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: afrayem onigwecher who wrote (10658)	11/1/2002 11:30:09 AM
From: StockDung	of 19428

Before Jefferies can try this approach in humans, the Food & Drug Administration wants proof it is safe to insert the gene. Jefferies, now chief science officer of startup GeneMax Corp. (GMXX ) in Blaine, Wash., believes the company should be able to answer the safety questions and start clinical trials in melanoma patients within 18 months. In a forthcoming paper, he will also present data showing that adding the TAP protein can bolster the immune response to infectious agents such as HIV and smallpox

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next